NFI schedules first quarter 2024 financial results and Annual Meeting of Shareholders
April 17, 2024 16:00 ET
|
NFI Group Inc
WINNIPEG, Manitoba, April 17, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in...
Cielo Announces Fiscal Q1 2024 Financial Results
September 27, 2023 17:01 ET
|
Cielo Waste Solutions Corp.
CALGARY, Alberta, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”), a waste‐to‐fuel company, today announced its financial results...
FRO – Q1 2023 Presentation
May 31, 2023 08:49 ET
|
Frontline plc.
Please find enclosed the presentation of Frontline plc´s first quarter 2023 results to be held on the webcast / conference call 31 May, 2023 at 15:00 CET. This information is subject to the...
FRO – First Quarter 2023 Results
May 31, 2023 01:30 ET
|
Frontline plc.
FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023 Frontline plc (the “Company” or “Frontline”), today reported unaudited results for the three months ended...
FRO – Invitation to Q1 2023 Results Conference Call and Webcast
May 25, 2023 06:58 ET
|
Frontline plc.
Frontline plc.’s preliminary first quarter 2023 results will be released on Wednesday May 31, 2023, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The...
ONWARD présente une mise à jour de son activité au premier trimestre ainsi que les faits marquants depuis le début de l’exercice
May 16, 2023 01:30 ET
|
ONWARD Medical
L’ARC-IM™ Lead implanté pour la première fois chez un humainNouvelle désignation de dispositif révolutionnaire décernée par la FDA américaine pour ARC Therapy™, portant le total à 910 brevets...
ONWARD rapporteert Q1 Business Update en hoogtepunten van het jaar
May 16, 2023 01:30 ET
|
ONWARD Medical
ARC-IM™ afleiding voor het eerst geïmplanteerd bij een mensNieuwe 'Breakthrough Device Designation' toegekend door de Amerikaanse FDA voor ARC Therapy™, waarmee het totaal op 9 komt10 bijkomende...
ONWARD Reports Q1 Business Update and Year-To-Date Highlights
May 16, 2023 01:30 ET
|
ONWARD Medical
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending and Issued...
Lavras Gold expands on wealth of discoveries in first quarter
May 15, 2023 16:15 ET
|
Lavras Gold Corp
The news release should be read in conjunction with Lavras Gold’s audited consolidated financial statements and management’s discussion and analysis for the three months ended March 31, 2023. Both are...
Entera Bio Announces Q1 2023 Financial Results and Corporate Updates
May 05, 2023 16:05 ET
|
Entera Bio Ltd.
JERUSALEM, May 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...